Cargando…
Glial Promoter Selectivity following AAV-Delivery to the Immature Brain
Recombinant adeno-associated virus (AAV) vectors are versatile tools for gene transfer to the central nervous system (CNS) and proof-of-concept studies in adult rodents have shown that the use of cell type-specific promoters is sufficient to target AAV-mediated transgene expression to glia. However,...
Autores principales: | von Jonquieres, Georg, Mersmann, Nadine, Klugmann, Claudia Bettina, Harasta, Anne Editha, Lutz, Beat, Teahan, Orla, Housley, Gary David, Fröhlich, Dominik, Krämer-Albers, Eva-Maria, Klugmann, Matthias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3683058/ https://www.ncbi.nlm.nih.gov/pubmed/23799030 http://dx.doi.org/10.1371/journal.pone.0065646 |
Ejemplares similares
-
Recombinant Human Myelin-Associated Glycoprotein Promoter Drives Selective AAV-Mediated Transgene Expression in Oligodendrocytes
por: von Jonquieres, Georg, et al.
Publicado: (2016) -
Dual-function AAV gene therapy reverses late-stage Canavan disease pathology in mice
por: Fröhlich, Dominik, et al.
Publicado: (2022) -
Uncoupling N-acetylaspartate from brain pathology: implications for Canavan disease gene therapy
por: von Jonquieres, Georg, et al.
Publicado: (2017) -
Loss of Central Auditory Processing in a Mouse Model of Canavan Disease
por: von Jonquieres, Georg, et al.
Publicado: (2014) -
Expression Pattern of the Aspartyl-tRNA Synthetase DARS in the Human Brain
por: Fröhlich, Dominik, et al.
Publicado: (2018)